Nemours Children's Hospital is now offering Lyfgenia gene therapy. The treatment aims to reduce pain crises and hospital visits for young patients.

The current path to CAR-T cell therapy is, by any measure, a logistical ordeal. A patient’s immune cells must be drawn out of ...

Automation in cell and gene therapy manufacturing promises lower costs, improved efficiency, and expanded access to life-saving treatments worldwide.

Abeona Therapeutics (ABEO) stock gets a "Buy" rating, driven by ZEVASKYN's commercial launch for RDEB and strong early demand signals. Read the full analysis here.

Researchers have identified a specific hormone produced by pancreatic beta cells as a direct driver of obesity-linked pancreatic cancer in mouse models, shifting scientific attention away from insulin ...

The company is establishing commercial production capabilities to fuel plans to launch autologous CAR-T cell therapies in China.

Following through with its sizable investment commitment in China, AstraZeneca on Thursday unveiled plans to build a commercial cell therapy manufacturing base and an innovation center dedicated to | ...

Dosed multiple Rett syndrome patients in REVEAL pivotal trial of TSHA-102, with enrollment advancing across multiple sites; on track to complete ...

New blinded data from ~45 patients to date in key pain and function scales and safety and tolerability of the Company’s ...

The technology is designed to simplify the bio-separation process while reducing manufacturing costs.

The researchers say that, to their knowledge, this is the first demonstration of programmable, site-specific integration of a large DNA payload into T cells in vivo.

For years, one of the most powerful weapons against certain blood cancers, called CAR-T cell therapy, has required an ...